New dopaminergic therapies for PD motor complications
Sign Up to like & getrecommendations! Published in 2022 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2021.108869
Abstract: BACKGROUND Motor complications, characterized by "off" periods - when anti-parkinsonian medications are ineffective - and dyskinesia, are the hallmark of advanced Parkinson's disease (PD). While levodopa is the gold standard PD medication in terms of… read more here.
Keywords: motor complications; new dopaminergic; dopaminergic therapies; motor ... See more keywords